Patient-derived homogenates have the considerable advantage over recombinant fibrils that they comprise the human tauopathy core structure and multiple human tau isoforms, in addition to bearing any complex hyperphosphorylation or other PTM patterns found in human tau fibrils [76]. Here, MAPT is linked to tauopathy.